ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $30,000 | -69.1% | 15,965 | -23.8% | 0.00% | – |
| Q2 2015 | $97,000 | 0.0% | 20,950 | -5.2% | 0.00% | – |
| Q1 2015 | $97,000 | +29.3% | 22,097 | +1.6% | 0.00% | – |
| Q4 2014 | $75,000 | -97.7% | 21,755 | -97.2% | 0.00% | -100.0% |
| Q3 2014 | $3,213,000 | -15.5% | 766,688 | +18.2% | 0.01% | -20.0% |
| Q2 2014 | $3,802,000 | -24.1% | 648,802 | -18.4% | 0.01% | -28.6% |
| Q1 2014 | $5,011,000 | +44.9% | 795,511 | +34.5% | 0.01% | +27.3% |
| Q4 2013 | $3,459,000 | +3.4% | 591,285 | -6.9% | 0.01% | -8.3% |
| Q3 2013 | $3,345,000 | +4.1% | 634,793 | +52.1% | 0.01% | -14.3% |
| Q2 2013 | $3,213,000 | – | 417,249 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |